RxSight, Inc. Payments to Acquire Short-term Investments
RxSight, Inc. (RXST) reported Payments to Acquire Short-term Investments of $193.78 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-08-05
- RxSight, Inc. payments to acquire short-term investments for the quarter ending 2026-06-30 was $93.39M, a 176.22% increase year-over-year.
- RxSight, Inc. payments to acquire short-term investments for the quarter ending 2026-03-31 was $100.39M, a 160.29% increase year-over-year.
- RxSight, Inc. payments to acquire short-term investments for the quarter ending 2025-12-31 was $98.48M, a 86.39% increase year-over-year.
- RxSight, Inc. payments to acquire short-term investments for the quarter ending 2025-09-30 was $68.42M, a 11.32% decline year-over-year.
- RxSight, Inc. payments to acquire short-term investments for fiscal 2025 was $239.28M, a 28.97% decline from fiscal 2024.
- RxSight, Inc. payments to acquire short-term investments for fiscal 2024 was $336.87M, a 23.71% increase from fiscal 2023.
- RxSight, Inc. payments to acquire short-term investments for fiscal 2023 was $272.31M, a 28.05% increase from fiscal 2022.
- RxSight, Inc. payments to acquire short-term investments for fiscal 2022 was $212.66M, a 32.94% increase from fiscal 2021.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $93.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $193.78M 10-Q · filed 2026-08-05 | $292.26M derived: sum of 3 quarters · filed 2026-08-05 | $360.69M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $100.39M 10-Q · filed 2026-05-06 | $198.87M derived: sum of 2 quarters · filed 2026-05-06 | $267.29M derived: sum of 3 quarters · filed 2026-05-06 | $301.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $98.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $166.90M derived: sum of 2 quarters · filed 2026-02-25 | $200.71M derived: sum of 3 quarters · filed 2026-08-05 | $239.28M 10-K · filed 2026-02-25 |
| 2025-09-30 | $68.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $102.23M derived: sum of 2 quarters · filed 2026-08-05 | $140.80M 10-Q · filed 2025-11-05 | $193.64M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $33.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $72.38M 10-Q · filed 2026-08-05 | $125.21M derived: sum of 3 quarters · filed 2026-08-05 | $202.37M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $38.57M 10-Q · filed 2026-05-06 | $91.40M derived: sum of 2 quarters · filed 2026-05-06 | $168.56M derived: sum of 3 quarters · filed 2026-05-06 | $327.68M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $52.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $129.99M derived: sum of 2 quarters · filed 2026-02-25 | $289.11M derived: sum of 3 quarters · filed 2026-02-25 | $336.87M 10-K · filed 2026-02-25 |
| 2024-09-30 | $77.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $236.28M derived: sum of 2 quarters · filed 2025-11-05 | $284.04M 10-Q · filed 2025-11-05 | $327.88M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $159.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $206.88M 10-Q · filed 2025-08-07 | $250.72M derived: sum of 3 quarters · filed 2026-02-25 | $322.80M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $47.76M 10-Q · filed 2025-05-07 | $91.60M derived: sum of 2 quarters · filed 2026-02-25 | $163.67M derived: sum of 3 quarters · filed 2026-02-25 | $212.46M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $43.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $115.92M derived: sum of 2 quarters · filed 2026-02-25 | $164.70M derived: sum of 3 quarters · filed 2026-02-25 | $272.31M 10-K · filed 2026-02-25 |
| 2023-09-30 | $72.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $120.85M derived: sum of 2 quarters · filed 2024-11-07 | $228.47M 10-Q · filed 2024-11-07 | $262.70M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $48.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $156.40M 10-Q · filed 2024-08-05 | $190.63M derived: sum of 3 quarters · filed 2025-02-25 | $264.49M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $107.62M 10-Q · filed 2024-05-06 | $141.85M derived: sum of 2 quarters · filed 2025-02-25 | $215.71M derived: sum of 3 quarters · filed 2025-02-25 | $245.50M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $34.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $108.09M derived: sum of 2 quarters · filed 2025-02-25 | $137.89M derived: sum of 3 quarters · filed 2025-02-25 | $212.66M 10-K · filed 2025-02-25 |
| 2022-09-30 | $73.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $103.65M derived: sum of 2 quarters · filed 2023-11-09 | $178.42M 10-Q · filed 2023-11-09 | $238.41M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $29.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $104.56M 10-Q · filed 2023-08-07 | $164.54M derived: sum of 3 quarters · filed 2023-08-07 | $259.53M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $74.77M 10-Q · filed 2023-05-09 | $134.75M derived: sum of 2 quarters · filed 2023-05-09 | $229.74M derived: sum of 3 quarters · filed 2023-05-09 | $229.74M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $59.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $154.97M derived: sum of 2 quarters · filed 2023-03-06 | $154.97M derived: sum of 3 quarters · filed 2023-03-06 | $159.97M 10-K · filed 2023-03-06 |
| 2021-09-30 | $94.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $94.99M derived: sum of 2 quarters · filed 2022-11-07 | $99.99M 10-Q · filed 2022-11-07 | $134.97M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $5.00M 10-Q · filed 2022-08-08 | $39.98M derived: sum of 3 quarters · filed 2022-08-08 | $54.97M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $5.00M 10-Q · filed 2022-05-05 | $39.98M derived: sum of 2 quarters · filed 2022-05-05 | $54.97M derived: sum of 3 quarters · filed 2022-05-05 | |
| 2020-12-31 | $34.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $49.97M derived: sum of 2 quarters · filed 2022-03-08 | $97.87M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $14.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $62.89M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $47.90M 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |